文献速递肿瘤 PET/CT核素与放射性配体治疗

免费开放的人工智能在PSMA PET-CT中检测盆腔淋巴结转移的表现与核医学医师相当

Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-04-27

本研究基于211例高危前列腺癌患者的[18F]PSMA-1007 PET-CT扫描,由三名独立读者标注疑似盆腔淋巴结转移,用161例训练和验证卷积神经网络,在50例独立测试组中评估AI方法与读者间一致性。AI检测盆腔淋巴结转移的敏感度为82%,人类读者平均敏感度为77%,平均每例患者假阳性1.8个。作者将AI工具免费开放给其他研究者,并强调独立验证对AI工具临床转化至关重要。

要点

  • AI方法检测盆腔淋巴结转移的敏感度为82%,人类读者平均为77%。
  • 平均每例患者假阳性数为1.8个,全队列假阴性病灶5-17个(取决于参考读者)。
  • AI方法已在www.recomia.org免费开放给研究者使用。

核心结论

  • AI可获得与医师相当的敏感度,且假阳性数量合理。
  • 读者间敏感度难以达到高水平,凸显了对自动化方法的需求。
  • 在AI工具获得临床使用资格的过程中,独立验证至关重要,并可在不同医院的研究中评估性能。
  • 作者已将AI工具免费开放给其他研究者。

研究设计与样本

  • 研究收集了211例高危前列腺癌患者的[18F]PSMA PET-CT扫描。
  • 由三名独立读者标注疑似盆腔淋巴结转移。
  • 卷积神经网络在161例患者的训练和验证组中开发与训练。
  • 在50例患者的独立测试组中评估AI方法性能及三名读者间观察者一致性。

主要发现

  • AI方法检测盆腔淋巴结转移的敏感度为82%,人类读者平均敏感度为77%。
  • 平均每例患者假阳性数为1.8个。
  • 全队列中假阴性病灶为5-17个,具体数量取决于以哪位读者作为参考。

临床怎么用

  • 作者认为AI可获得与医师相当的敏感度且假阳性数量合理。
  • 作者指出读者间敏感度难以达到高水平,凸显了对自动化方法的需求。
  • 作者强调独立验证对AI工具获得临床使用资格至关重要,并已将AI工具免费开放给其他研究者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to develop and validate an artificial intelligence (AI)-based method using convolutional neural networks (CNNs) for the detection of pelvic lymph node metastases in scans obtained using [18F]PSMA-1007 positron emission tomography-computed tomography (PET-CT) from patients with high-risk prostate cancer. The second goal was to make the AI-based method available to other researchers. METHODS: [18F]PSMA PET-CT scans were collected from 211 patients. Suspected pelvic lymph node metastases were marked by three independent readers. A CNN was developed and trained on a training and validation group of 161 of the patients. The performance of the AI method and the inter-observer agreement between the three readers were assessed in a separate test group of 50 patients. RESULTS: The sensitivity of the AI method for detecting pelvic lymph node metastases was 82%, and the corresponding sensitivity for the human readers was 77% on average. The average number of false positives was 1.8 per patient. A total of 5-17 false negative lesions in the whole cohort were found, depending on which reader was used as a reference. The method is available for researchers at www.recomia.org . CONCLUSION: This study shows that AI can obtain a sensitivity on par with that of physicians with a reasonable number of false positives. The difficulty in achieving high inter-observer sensitivity emphasizes the need for automated methods. On the road to qualifying AI tools for clinical use, independent validation is critical and allows performance to be assessed in studies from different hospitals. Therefore, we have made our AI tool freely available to other researchers.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Trägårdh E, Enqvist O, Ulén J, et al. Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians. Eur J Nucl Med Mol Imaging. 2022. PMID: 35475912. doi:10.1007/s00259-022-05806-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。